By using custom ImmunoChip arrays and replication analysis of MS-GWAS datasets, IMSGC identified 48 novel risk variants for MS, including GALC (rs74796499), with a joint p-value of 2.4E-20 (Beecham et al., 2013). This evidence concerns the gene GALC and myeloid sarcoma.